Ocugen, Inc. (OCGN)
1.445
-0.01
(-0.69%)
USD |
NASDAQ |
May 07, 12:18
Ocugen SG&A Expense (TTM) : 21.13M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| REGENXBIO, Inc. | 82.86M |
| Sarepta Therapeutics, Inc. | 491.72M |
| Krystal Biotech, Inc. | 114.19M |
| Phathom Pharmaceuticals, Inc. | 239.25M |
| Catalyst Pharmaceuticals, Inc. | 171.18M |